Terminated PHASE4 INTERVENTIONAL NCT00047606

Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

Phase 4 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Caucasian and Japanese Subjects C-02-32.

Sponsor: Alcon Research

Conditions Ocular Hypertension Open-angle Glaucoma

Interventions IOP Lowering Medications

Updated 7 times since 2017 Last updated: Aug 16, 2012 Started: Aug 31, 2002 Primary completion: Nov 30, 2003 Completion: Nov 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Management Decision

Listed as NCT00047606, this PHASE4 trial focuses on Ocular Hypertension and Open-angle Glaucoma and remains terminated or withdrawn. Sponsored by Alcon Research, it has been updated 7 times since 2002, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE4
Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alcon Research

Data source: Alcon Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.